Baxa Corporation Bolsters Patient Safety with ExactaMix® Compounder Software Upgrade
Baxa Corporation, a leading provider of medical devices and systems that automate pharmacy operations, has released a software upgrade for its ExactaMix® Automated Compounding Devices (ACD). The new functionality includes 14 updates that provide Directors of Pharmacy with enhanced patient safety measures and features.
Baxa Corporation, a leading provider of medical devices and systems that automate pharmacy operations, has released a software upgrade for its ExactaMix® Automated Compounding Devices (ACD). The new functionality includes 14 updates that provide Directors of Pharmacy with enhanced patient safety measures and features.
- Water is now the default calibration ingredient for the US market. The calibration source was redefined to allow multiple water calibration products.
- The current patient formula is unloaded when the user exits the compounder screen, reducing the potential for the user to pump a wrong formula into the bag.
- New priming process improves the purging of air bubbles in the inlets prior to pumping, enhancing the user prime process.
- Integration with DoseEdge® Pharmacy Workflow Manager enables pharmacies to export MixCheck(TM) Report data for use with DoseEdge TPN.
- State-of-the-art Baxa compounding technology delivers final bag accuracies within + 3% with barcode ingredient verification, and pumps a typical three-liter nutrition bag in approximately 3.5 minutes - nearly two times faster than the industry average. ExactaMix provides volumetric delivery and gravimetric check with the ability to mix both micro and macro ingredients as low as 0.2 mL. ExactaMix compounding efficiency enables pharmacy professionals to focus on patient care with the confidence that safety, regulatory compliance and preparation accuracy goals are met.